ClinConnect ClinConnect Logo
Search / Trial NCT06457373

Demineralized Dentin Allograft Versus Demineralized Dentin Autograft for Socket Preservation

Launched by HORUS UNIVERSITY · Jun 7, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Socket Preservation Impacted Mandibular Third Molar Alveolar Ridge Augmentation

ClinConnect Summary

This clinical trial is looking to compare two different methods for helping preserve the bone structure in the jaw after a tooth extraction, specifically when removing impacted lower wisdom teeth. The two methods being studied are Demineralized Dentin Allograft (DDA), which uses bone material from a donor, and Demineralized Dentin Autograft (Auto-DD), which uses the patient's own bone. Researchers want to see which method works better in maintaining the shape and health of the jawbone after surgery.

To be eligible for this trial, participants need to be between 25 and 35 years old and have specific dental conditions, including having similar difficulty with both lower wisdom teeth that need to be removed. They should also be healthy without any serious medical conditions or habits like smoking. If you join the study, you'll have the chance to receive one of the two treatments, and your progress will be monitored to see how well the bone structure is preserved. It's important to note that this trial is not currently recruiting participants, so it may not be open for enrollment right now.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients aged between 25 to 35 years old.
  • 2. Patients scored as (ASA I).
  • 3. No adverse habits such as smoking, tobacco chewing, alcohol.
  • 4. Patients having bilaterally impacted mandibular third molar with similar degree of difficulty according to (Kim JY, et al).
  • 5. The recipient alveolar sockets are free of any pre-existing periapical pathology, based on x-ray.
  • 6. Alveolar sockets with a depth of 5 mm or more, using periodontal probe for assessment.
  • 7. Patients sign a consent for all procedures.
  • Exclusion Criteria:
  • 1) Pregnant or lactating patients. 2) Relevant systemic diseases. 3) Patients with history of chemotherapy or radiotherapy.

About Horus University

Horus University is a leading academic institution dedicated to advancing medical research and education. With a commitment to innovative healthcare solutions, the university actively sponsors clinical trials that aim to enhance treatment methodologies and patient outcomes. By fostering collaboration between researchers, clinicians, and industry partners, Horus University leverages its expertise and resources to conduct rigorous, ethically sound studies that contribute to the scientific community and improve healthcare practices globally.

Locations

Damietta, New Damietta, Egypt

Patients applied

0 patients applied

Trial Officials

Mohamed Habib, B.D.S

Principal Investigator

Faculty of Dentistry- Horus University in Egypt

Ahmed Khalil

Study Director

Faculty of Dentistry- Horus University in Egypt

Eman Abdelsalam

Study Director

Faculty of Dentistry- Horus University in Egypt

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported